【Introduction】
Product Name: Human SLC34A2 Antibody (LifastuzumAb, Research Use)
Catalog Number: NBR-0875
Target Name: SLC34A2
Trade Name: LifastuzumAb
Antibody Drug Description: Lifastuzumab vedotin DNIB0600A (LIFA) is an antibody drug conjugate (ADC) that comprises a humanized IgG1 anti-NaPi2b monoclonal antibody (MNIB2126A) and a potent anti-mitotic agent (monomethyl auristatin E [MMAE]) linked through a protease-labile linker, maleimidocaproylvaline-citrulline-p-aminobenzyloxycarbonyl (MC-VC-PAB).
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: SLC34A2
Synonyms: NAPI-3B
Target Description: Involved in actively transporting phosphate into cells via Na(+) cotransport.
Ensembl: ENSG00000157765
Uniprot: O95436